Michael Wood, DVM, PhD, DACVIM (SAIM)


Department of Medical Sciences
Office: 3258

Michael Wood, DVM, PhD, DACVIM (SAIM)


Dr. Wood’s research focuses on the mucosal response of the lower urinary tract to bacterial infection, more specifically the anti-inflammatory and barrier restoring effects of interleukin-6 and glycosaminoglycans. Clinically his research includes examination of non-antibiotic alternative treatments to repair urothelial defects and prevent infection, risk factors for bacteriuria, and biomarkers of asymptomatic and clinical bacteriuric patients.


Currently, Dr. Wood is a Clinical Associate Professor of Small Animal Internal Medicine.

Clinical Interests


Recent Publications

  1. Lepold A, Tesfamichael D, Hartmann F, Wiley C, Wood MW. Comparison of urine fibrinogen and interleukin-6 concentrations between healthy dogs and dogs with risk factors for enterococcal bacteriuria. American Journal of Veterinary Research, 2021 Oct; 82(10):846-852.
  2. Wood MW, Lepold A, Tesfamichael D, Lasarev MR. Risk factors of enterococcal bacteriuria in dogs: a retrospective study. Journal of Veterinary Internal Medicine, 2020 Oct 2. Doi:10.1111/jvim.15916.
  3. Wood MW, Barrett-Wilt G. Effect of twice-daily oral administration of a chondroitin sulfate-containing supplement on urine chondroitin sulfate concentrations in dogs. American Journal of Veterinary Research, 2019;80(8):799-805.
  4. Wood MW. The effect of intramuscular polysulfated glycosaminoglycan injections on urine glycosaminoglycan concentrations in dogs. Journal of the American Holistic Veterinary Medicine Association, 2019 Winter; 53:50-55.